This activity is jointly sponsored by Wake Forest University School of Medicine and the World Institute of Pain.
WIP Pain Congress, New York, March 2009
Accreditation Statement
The Wake Forest University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The Wake Forest University School of Medicine designates this education activity for a maximum of 16.75 AMA PRA Category 1 CreditsTM. Physicians should only claim credit commensurate with the extent of their participation in the activity.
AMA PRA Category 1 CreditsTM are recognized by the European Accreditation Council for Continuing Medical Education (EACCME). To convert AMA PRA credit to EACCME credit, contact the EACCME at (http://www.uems.net)
Learner Objectives
At the conclusion of this CME activity, the learner should better be able to identify new and current themes in processing of pain information (including afferent transduction processes and targeted therapies, and inflammatory cascades and pain); modeern themes in neuropathic pain (including commonalities and similarities in the clinical neurologic pain phenotype, and new targets in neuropathic pain); and imaging the pain pathways (including the complexity of the first link in the dorsal horn, and brain pathways acitivated by pain stimuli).
The learner will be better able to describe current and new advancements in treatments and therapies for pain medicine and research across multiple disciplines to improve patient outcomes and relieve suffering. Those disciplines include but are not limited to cancer pain management, fibromyalgia, geriatric pain, neuropathic pain, spinal cord injury, perdiatric pain, trigeminal neuralgia and atypcal facial pain, visceral pain; as well as the expanding role of radiofrequency in interventional pain medicine, pathopysiology and diagnosis of radicular pain, pain as a disease, overview of palliative care, post amputation pain, political affairs and economic reimbursement for interventional pain medicine, and more.
Disclosure of Financial Relationships and Resolution of Conflicts of Interest
The Wake Forest University School of Medicine (WFUSM) Policy on Full Disclosure For Continuing Medical Education Activities is designed to ensure quality, objective, balanced, and scientifically rigorous CME activities. All individuals in a position to influence and/or control the content of WFUSM CME activities are required to disclose to the WFUSM and subsequently to learners that they either have no relevant financial relationships or any financial relationships with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services discussed in CME activities. All potential conflicts of interest are identified and resolved prior to an individual’s confirmation of service at a WFUSM CME activity. Beyond disclosure of financial relationships, WFUSM CME faculty are required to disclose to the WFUSM and to learners when they plan to discuss or demonstrate pharmaceuticals and/or medical devices that are not approved by the FDA and/or medical or surgical procedures that involve an unapproved or “off-label” use of an approved device or pharmaceutical. The WFUSM is committed to providing learners with commercially unbiased CME activities.